Pegvaliase
Records for this ingredient, by country (identity only).
ATC A16AB19 · 5 markets · 14 records
AU 4 records · 3 shown of 3
- 20 mg per mL / per unit basis not statedinjectionPALYNZIQ pegvaliase 20 mg/mL solution for injection pre-filled syringe
- 10 mg per mL / per unit basis not statedinjectionPALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe
- 2.5 mg per mL / per unit basis not statedinjectionPALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 3 records · 3 shown of 3
CA 3 records · 3 shown of 3
TW 3 records · 3 shown of 3
- 20 mg per mL / per unit basis not statedinjectionPalynziq Solution for Injection 10mg苯能清 20毫克注射液
- 10 mg per mL / per unit basis not statedinjectionPalynziq Solution for Injection 10mg苯能清 10毫克注射液
- 2.5 mg per mL / per unit basis not statedinjectionPalynziq Solution for Injection 10mg苯能清 2.5毫克注射液
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | CA | AU | TW | EU |
|---|---|---|---|---|---|
| 20 mg per mL / per unit basis not stated cannot compare injection | Palynziq | PALYNZIQ pegvaliase 20 mg/mL solution for injection pre-filled syringe | Palynziq Solution for Injection 10mg 苯能清 20毫克 | ||
| 10 mg per mL / per unit basis not stated cannot compare injection | PALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe | Palynziq Solution for Injection 10mg 苯能清 10毫克 | |||
| 2.5 mg per mL / per unit basis not stated cannot compare injection | PALYNZIQ pegvaliase 2.5 mg/0.5 mL solution for injection pre-filled syringe | Palynziq Solution for Injection 10mg 苯能清 2.5毫克 | |||
| 20 mg per mL / per unit basis not stated cannot compare liquid | Palynziq | ||||
| 10 mg per mL / per unit basis not stated cannot compare liquid | Palynziq | ||||
| 2.5 mg per mL / per unit basis not stated cannot compare liquid | Palynziq | ||||
| 10 mg/0.5 mL injection | Palynziq | ||||
| 2.5 mg/0.5 mL injection | Palynziq | ||||
unknown | Palynziq | Palynziq |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 CA 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.